GMO mustard approval in India stalled by lawsuit alleging scientists deceived public on crop’s benefits

mustard e

India’s long-standing push to approve genetically modified (GM) food crops has been controversially delayed, after an environmental campaigner launched a lawsuit that accuses scientists of deceiving the public about the benefits of transgenic mustard.

…

[O]n 7 October, India’s Supreme Court agreed to hear a case brought by Aruna Rodrigues, an anti-GM campaigner who wants a moratorium on the crop’s approval until it undergoes an independent evaluation … Rodrigues says that both Pental and India’s regulatory authorities have exaggerated the benefits of transgenic mustard, and that non-GM mustard could be just as high-yielding. Tests overseen by the environment ministry’s Genetic Engineering Appraisal Committee (GEAC) didn’t pit the new crop against its best possible competitors, she says. She accuses Pental and the authorities of deliberate deception.

Deepak Pental, a plant geneticist at the University of Delhi who has led research into the crop, dismisses these criticisms. The trials were designed to test health and safety, he says, not to stringently compare yields against all competitors. It’s possible, he says, that non-GM varieties might produce higher yields than his first GM generation—but this hasn’t been tested.

…

No one knows when the Supreme Court will decide on Rodrigues’s complaints, says Kabir Dixit, a lawyer in Delhi—but India’s government has already agreed that it needs the court’s permission before it can approve the mustard’s commercial release.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: India’s First GM Food Crop Held Up by Lawsuit

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
MAHA-MOMS-Supporters-at-the-Rally
Viewpoint: How 'MAHA men' hijacked the female-built food and wellness movement
Dissolving-Tablets-in-Waves
Viewpoint: How the anti-abortion movement twists medical facts and promotes science misinformation
Screenshot-2026-10-07-at-1.03.15-PM
Anti-vaxxers’ double whammy: Exaggerated vaccine fears have fueled measles outbreaks and preventable deaths—and left survivors more vulnerable to other infections for years
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
Executive-Greeting-in-a-Futuristic-Boardroom
Viewpoint: RFK Jr. touts AI to guide health care…but searches using the technology he champions expose him as scientifically illiterate
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Caution-Taped-Fresh-Produce-Aisle
Should we be afraid of our food?
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Golden Wheat Under a Starry Sky
Viewpoint: ‘Bureaucratic and economic obstacles’ to agricultural biotechnology: Europe creeps into the 21st century, but blocks remain
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.